Results 101 to 110 of about 13,217 (287)

Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice [PDF]

, 2018
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) worsens oral health-related quality of life. Most BRONJ occurs in multiple myeloma or metastatic breast cancer patients treated with bisphosphonate/chemotherapeutic combination therapies ...
Muneteru Sasaki, Sawase, Takashi, Kazunori Nakajima, Hayano, Hiroki, Kuroshima, Shinichiro, Nakajima, Kazunori, Takashi Sawase, Hiroki Hayano, Shinichiro Kuroshima, Saki Tamaki, Sasaki, Muneteru, Tamaki, Saki   +11 more
core   +1 more source

Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab

Oral Diseases, EarlyView.
ABSTRACT Introduction Medication‐Related Osteonecrosis of the Jaw (MRONJ) is a severe adverse effect of antiresorptive and antiangiogenic treatment, primarily in osteoporotic and oncologic patients. The disease is characterized by persistent jawbone necrosis that results in significant impairment of the quality of life of involved patients.
Omar Ghanaiem, Gavriel Chaushu, Daya Masri   +2 more
wiley   +1 more source

Osteonecrosis of the jaw in association to bisphosphonates [PDF]

, 2008
Thesis (M.A.)--Boston University, 2008.The use of bisphosphonate has become more widespread for the treatment of bone metastasis, multiple myeloma, osteoporosis, Paget's disease and other bone malignancies.
Mattos, Ana Carolina Lopes
core  

The Role of the Mylohyoid Line in the Spread of Mandibular Odontogenic Deep Neck Infection

Oral Diseases, EarlyView.
ABSTRACT Introduction Although mandibular odontogenic deep neck infections are occasionally fatal, the transmission pathway has not been elucidated. Materials and Methods This multicenter retrospective study was comprised of the patients of both sexes who were over 18 years of age and who had mandibular odontogenic deep neck abscesses.
Eiji Iwata, Kyoichi Obata, Shogo Kikuta, Naoki Kaneko, Kotaro Sato, Norio Kitagawa, Yohei Takeshita, Katsuhisa Matsuo, Junsei Sameshima, Akira Tachibana, Shintaro Kawano, Jingo Kusukawa, Masaya Akashi, Soichiro Ibaragi, Joe Iwanaga   +14 more
wiley   +1 more source

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database

, 2018
Ayaka Inada, Keiko Hosohata, Saki Oyama, Iku Niinomi, Yasuhiro Mori, Yuki Yamaguchi, Mayako Uchida, Kazunori Iwanaga Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka 569-1094, Japan ...
Uchida M, Niinomi I, Iwanaga K, Mori Y, Hosohata K, Inada A, Yamaguchi Y, Oyama S   +7 more
core  

Medication related osteonecrosis of the jaw around previously osseointegrated implants: about 5 cases

, 2021
Medication related osteonecrosis of the jaw around previously osseointegrated implants: about 5 ...
Massaad, Jean, Magremanne, Michèle, 25th congress of the european association for cranio maxillo facial surgery - EACMFS 2021   +2 more
core  

Is Fluorescence‐Guided Surgery Reliable for the Treatment of MRONJ? A Systematic Review and Meta‐Analysis

Oral Diseases, EarlyView.
ABSTRACT Background Identification of healthy bone margins is a critical step in the surgical resective treatment of medication‐related osteonecrosis of the jaw (MRONJ). Fluorescence‐guided surgery (FGS) has been proposed as a method to identify resection margins and improve clinical outcomes.
Paolo De Angelis, Alessandro Donato Tescione, Ivan Michele Aniceto, Cosimo Rupe, Gioele Gioco, Romeo Patini, Carlo Lajolo   +6 more
wiley   +1 more source

Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients

, 2013
Henrik Gammelager,1 Claus Sværke,1 Sven Erik Noerholt,2 Bjarne Neumann-Jensen,3 Fei Xue,4 Cathy Critchlow,4 Johan Bergdahl,5 Ylva Trolle Lagerros,5 Helle Kieler,5 Grethe S Tell,6 Vera Ehrenstein11Department of Clinical Epidemiology, Aarhus ...
Noerholt SE, Xue F, Bergdahl J, Gammelager H, Tell GS, Critchlow C, Ehrenstein V, Sværke C, Kieler H, Lagerros YT, Neumann-Jensen B   +10 more
core  

Mechanism, prevention, risk assessment and treatment in bisphosphonates induced osteonecrosis of the jaw [PDF]

, 2009
PURPOSE: Bisphophonates are drugs used to suppress osteoclastic activity and to treat osteoporosis, Paget's disease of bone and bone metastasis. The purpose of this report is to review the literatures on bisphopsphonates use that could affect bone ...
김창성, 조규성, 정의원, 채중규, 최성호, 김종관   +5 more
core  

Knowledge of Brazilian dentists about bisphosphonate-associated osteonecrosis of the jaw

Brazilian Dental Science
Osteonecrosis of the jaw associated with bisphosphonate use is a matter of utmost importance in clinical practice for the safe treatment of patients using this medication.
Thainara Alexia Marinho de Souza , Gabriela Ribeiro Zucco, Janete Dias Almeida   +2 more
doaj   +1 more source